4.8 Article

Total synthesis and study of 6-deoxyerythronolide B by late-stage C-H oxidation

Journal

NATURE CHEMISTRY
Volume 1, Issue 7, Pages 547-551

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEM.351

Keywords

-

Funding

  1. National Institutes of Health/National Institute of General Medicine [GM076153]
  2. Eli Lilly
  3. Bristol-Myers Squibb
  4. Pfizer
  5. Amgen
  6. R. C. Fuson graduate fellowship
  7. Roche Excellence in Chemistry Award

Ask authors/readers for more resources

Among the frontier challenges in chemistry in the twenty-first century are the interconnected goals of increasing synthetic efficiency and diversity in the construction of complex molecules. Oxidation reactions of C-H bonds, particularly when applied at late stages of complex molecule syntheses, hold special promise for achieving both these goals. Here we report a late-stage C-H oxidation strategy in the total synthesis of 6-deoxyerythronolide B (6-dEB), the aglycone precursor to the erythromycin antibiotics. An advanced intermediate is cyclized to give the 14-membered macrocyclic core of 6-dEB using a late-stage (step 19 of 22) C-H oxidative macrolactonization reaction that proceeds with high regio-, chemo-and diastereoselectivity (>40:1). A chelate-controlled model for macrolactonization predicted the stereochemical outcome of C-O bond formation and guided the discovery of conditions for synthesizing the first diastereomeric 13-epi-6-dEB precursor. Overall, this C-H oxidation strategy affords a highly efficient and stereochemically versatile synthesis of the erythromycin core.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available